427 related articles for article (PubMed ID: 29959725)
21. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
Spechler SJ
Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
[TBL] [Abstract][Full Text] [Related]
22. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
[TBL] [Abstract][Full Text] [Related]
23. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
Matsumura T; Sonoda M; Okimoto K; Dao HV; Takahashi S; Akizue N; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Taida T; Kikuchi A; Fujie M; Kato J; Kato N
Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462
[TBL] [Abstract][Full Text] [Related]
24. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
[TBL] [Abstract][Full Text] [Related]
25. Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.
Stern EK; Carlson DA; Falmagne S; Hoffmann AD; Carns M; Pandolfino JE; Hinchcliff M; Brenner DM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 29110377
[TBL] [Abstract][Full Text] [Related]
26. Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms.
Ribolsi M; Guarino MPL; Tullio A; Cicala M
Dig Liver Dis; 2020 Feb; 52(2):173-177. PubMed ID: 31623954
[TBL] [Abstract][Full Text] [Related]
27. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
Frazzoni M; Frazzoni L; Tolone S; De Bortoli N; Savarino V; Savarino E
Am J Gastroenterol; 2018 May; 113(5):670-676. PubMed ID: 29681623
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
29. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
31. Management of the patient with incomplete response to PPI therapy.
Kahrilas PJ; Boeckxstaens G; Smout AJ
Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):401-14. PubMed ID: 23998978
[TBL] [Abstract][Full Text] [Related]
32. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring.
Xiao Y; Liang M; Peng S; Zhang N; Chen M
J Gastroenterol Hepatol; 2016 Feb; 31(2):350-4. PubMed ID: 26202002
[TBL] [Abstract][Full Text] [Related]
33. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
[TBL] [Abstract][Full Text] [Related]
34. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
[TBL] [Abstract][Full Text] [Related]
35. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
de Bortoli N; Martinucci I; Savarino E; Tutuian R; Frazzoni M; Piaggi P; Bertani L; Furnari M; Franchi R; Russo S; Bellini M; Savarino V; Marchi S
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1082-8.e1. PubMed ID: 25499991
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
[TBL] [Abstract][Full Text] [Related]
37. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
[TBL] [Abstract][Full Text] [Related]
38. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
39. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring.
Frazzoni M; Conigliaro R; Melotti G
Dig Dis Sci; 2011 Apr; 56(4):1099-106. PubMed ID: 20737211
[TBL] [Abstract][Full Text] [Related]
40. Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance.
de Bortoli N; Gyawali CP; Frazzoni M; Tolone S; Frazzoni L; Vichi E; Visaggi P; Bellini M; Marabotto E; Penagini R; Savarino V; Marchi S; Savarino EV
Neurogastroenterol Motil; 2020 Dec; 32(12):e13919. PubMed ID: 32573065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
